Login

CEO Erik Kinnman presents Sprint Bioscience - Erik Kinnman, CEO, Sprint Bioscience 00:00:00

Share On Facebook Share On Twitter

CEO Erik Kinnman presents Sprint Bioscience

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Chuck Smith Reflects on His Journey from Dixie Elixirs to B Rock Brands
00:10:00
Interview with James Fox, Managing Director of PNX Metals Limited, at 121 Mining Investment London 2019
00:10:00
Insights on Financial Markets and Pension Impact from CEO Derek Kelly | Derek Kelly, CEO, Hilltop Financial Planning.
00:00:00
WGBY features an overview of FuelCell Energy, highlighting its operations and significance within the energy sector | JASON FEW, PRESIDENT, CHIEF EXECUTIVE OFFICER, FUELCELL ENERGY INC
00:10:00
From Immigrant to Influencer: Alex Vynokur's Journey to Leading a $28 Billion Company | Alex Vynokur, CEO , BetaShares .
00:10:00
"Empowering Couples: The Art of Money Conversations | Meredith Moore | TEDxAtlantaWomen"
00:10:00
Kincora Copper: Advancing Significant Copper-Gold Exploration in Australia's Macquarie Arc
00:10:00
Insights into Macro Trends and Investment Strategy: A Discussion with Karen Karniol-Tambour, Co-CIO of Bridgewater Associates, at GIC Insights 2023
00:10:00
Strategic Metals: Yukon Exploration and Investment Overview
00:10:00
The interview features Peter Kaufman, President of Gordian Group LLC, discussing insights on mergers and acquisitions (M&A), restructuring, and investment strategies.
00:10:00
Sometimes we had Doubt is our own Product |David Breger,Director of Product, Google
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience

© 2026 Nehu